Australian researchers may have found a breakthrough treatment for lupus. In a study published in Nature Communications on Feb. 6, scientists at Monash University revealed that they were able to "fix" ...
CAR cell therapy is a new type of therapy that has been used in cancer and is now in development for potential treatment of lupus and other autoimmune diseases. CAR cell therapies carry a modified ...
Dermatologists long reluctant to tackle cutaneous lupus erythematosus may be more open to treating patients with approvals ...
A recent review published in Current Molecular Pharmacology explores the therapeutic potential of melatonin in systemic lupus ...
INDIANAPOLIS (WISH) — Lupus is a debilitating autoimmune disease that affects around 1.5 million Americans. Now, new research shows a therapy that’s been used for cancer patients may help people with ...
Rheumatology — the study of immune-system-driven diseases of the bones, joints, muscles, and in-betweens — has inherited plenty of hand-me-downs from cancer research. For example, there are ways of ...
Roche has received approval from the European Commission (EC) for its humanised monoclonal antibody Gazyva/Gazyvaro ...
The immune system is made up of different types of cells, which have different roles in protecting the body from infection. One type of immune cell called a B cell creates antibodies that attack ...
Approval based on phase II NOBILITY and phase III REGENCY studies showing superiority of Gazyva/Gazyvaro over standard therapy alone1,2Gazyva/Gazyvaro is the only anti-CD20 antibody to demonstrate a ...
Rheumatology and nephrology experts provide an overview of the pharmacologic treatment options in lupus nephritis and discuss recent FDA approved therapies belimumab and voclosporin. German Hernandez, ...
Please provide your email address to receive an email when new articles are posted on . Chimeric antigen receptor T-cell therapy improves not only lupus disease activity but also other related ...
The optimum therapy for patients with lupus nephritis is a hotly debated topic. Prospective randomized studies in patients with proliferative lupus nephritis have established the superiority of ...